Yahoo Canada Web Search

Search results

  1. 21 hours ago · July 8, 2024 at 9:32 a.m.·1 min read. (Reuters) - Shares of biotech company HilleVax plunged 88.6% to $1.60 in premarket trade on Monday, after its vaccine to prevent gastroenteritis caused by norovirus failed to meet the main goal of a mid-stage trial in infants. The vaccine, named HIL-214, showed an efficacy of only 5%, failing to meet the ...

  1. People also search for